HALOZYME THERAPEUTICS, INC. Investing Cash Flow
HALOZYME THERAPEUTICS, INC. (HALO) reported Investing Cash Flow of -$65.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$62.66M, a 173.91% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$2.88M.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$741.79M, a 2616.24% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $201.61M.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$545.81M.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$262.72M.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$96.91M.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$487.00M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$62.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$65.54M 10-Q · filed 2026-08-06 | -$807.33M derived: sum of 3 quarters · filed 2026-08-06 | -$605.72M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$2.88M 10-Q · filed 2026-05-11 | -$744.66M derived: sum of 2 quarters · filed 2026-05-11 | -$543.06M derived: sum of 3 quarters · filed 2026-05-11 | -$458.27M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$741.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$540.18M derived: sum of 2 quarters · filed 2026-02-17 | -$455.39M derived: sum of 3 quarters · filed 2026-08-06 | -$545.81M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $201.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $286.40M derived: sum of 2 quarters · filed 2026-08-06 | $195.97M 10-Q · filed 2025-11-03 | $225.46M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $84.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$5.63M 10-Q · filed 2026-08-06 | $23.85M derived: sum of 3 quarters · filed 2026-08-06 | -$143.64M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$90.42M 10-Q · filed 2026-05-11 | -$60.94M derived: sum of 2 quarters · filed 2026-05-11 | -$228.43M derived: sum of 3 quarters · filed 2026-05-11 | -$270.46M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $29.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$138.00M derived: sum of 2 quarters · filed 2026-02-17 | -$180.04M derived: sum of 3 quarters · filed 2026-02-17 | -$262.72M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | -$167.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$209.52M derived: sum of 2 quarters · filed 2025-11-03 | -$292.20M 10-Q · filed 2025-11-03 | -$300.49M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | -$42.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$124.72M 10-Q · filed 2025-08-05 | -$133.01M derived: sum of 3 quarters · filed 2026-02-17 | -$216.46M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | -$82.68M 10-Q · filed 2025-05-06 | -$90.97M derived: sum of 2 quarters · filed 2026-02-17 | -$174.42M derived: sum of 3 quarters · filed 2026-02-17 | -$119.43M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | -$8.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$91.74M derived: sum of 2 quarters · filed 2026-02-17 | -$36.75M derived: sum of 3 quarters · filed 2026-02-17 | -$96.91M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | -$83.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$28.46M derived: sum of 2 quarters · filed 2024-10-31 | -$88.62M 10-Q · filed 2024-10-31 | -$90.36M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $54.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$5.17M 10-Q · filed 2024-08-06 | -$6.91M derived: sum of 3 quarters · filed 2025-02-18 | -$7.92M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | -$60.16M 10-Q · filed 2024-05-07 | -$61.91M derived: sum of 2 quarters · filed 2025-02-18 | -$62.92M derived: sum of 3 quarters · filed 2025-02-18 | -$497.86M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$2.75M derived: sum of 2 quarters · filed 2025-02-18 | -$437.70M derived: sum of 3 quarters · filed 2025-02-18 | -$487.00M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$435.95M derived: sum of 2 quarters · filed 2023-11-06 | -$485.26M 10-Q · filed 2023-11-06 | -$784.73M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | -$434.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$484.25M 10-Q · filed 2023-08-08 | -$783.72M derived: sum of 3 quarters · filed 2024-02-20 | -$800.67M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | -$49.30M 10-Q · filed 2023-05-09 | -$348.77M derived: sum of 2 quarters · filed 2024-02-20 | -$365.73M derived: sum of 3 quarters · filed 2024-02-20 | -$410.34M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | -$299.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$316.42M derived: sum of 2 quarters · filed 2024-02-20 | -$361.04M derived: sum of 3 quarters · filed 2024-02-20 | -$406.29M 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | -$16.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$61.57M derived: sum of 2 quarters · filed 2022-11-08 | -$106.82M 10-Q · filed 2022-11-08 | -$48.38M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | -$44.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$89.87M 10-Q · filed 2022-08-09 | -$31.43M derived: sum of 3 quarters · filed 2023-02-21 | -$61.52M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | -$45.25M 10-Q · filed 2022-05-10 | $13.19M derived: sum of 2 quarters · filed 2023-02-21 | -$16.90M derived: sum of 3 quarters · filed 2023-02-21 | -$5.00M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $58.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $28.35M derived: sum of 2 quarters · filed 2023-02-21 | $40.24M derived: sum of 3 quarters · filed 2023-02-21 | $78.35M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | -$30.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$18.20M derived: sum of 2 quarters · filed 2021-11-02 | $19.91M 10-Q · filed 2021-11-02 | -$102.91M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | $11.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $50.01M 10-Q · filed 2021-08-09 | -$72.81M derived: sum of 3 quarters · filed 2022-02-22 | -$31.81M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | $38.11M 10-Q · filed 2021-05-10 | -$84.71M derived: sum of 2 quarters · filed 2022-02-22 | -$43.71M derived: sum of 3 quarters · filed 2022-02-22 | $3.75M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | -$122.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$81.82M derived: sum of 2 quarters · filed 2022-02-22 | -$34.36M derived: sum of 3 quarters · filed 2022-02-22 | -$5.55M 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | $41.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $88.46M derived: sum of 2 quarters · filed 2020-11-02 | $117.27M 10-Q · filed 2020-11-02 | $128.08M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $47.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $76.27M 10-Q · filed 2020-08-10 | $87.08M derived: sum of 3 quarters · filed 2021-02-23 | $122.27M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $28.81M 10-Q · filed 2020-05-11 | $39.62M derived: sum of 2 quarters · filed 2021-02-23 | $74.81M derived: sum of 3 quarters · filed 2021-02-23 | $67.21M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $10.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $46.00M derived: sum of 2 quarters · filed 2021-02-23 | $38.39M derived: sum of 3 quarters · filed 2021-02-23 | $2.49M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $35.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $27.58M derived: sum of 2 quarters · filed 2019-11-12 | -$8.32M 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | -$7.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$43.51M 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | -$35.90M 10-Q · filed 2019-05-07 | |||||||
| 2017-12-31 | -$163.73M 10-K · filed 2020-02-24 | |||||||
| 2016-12-31 | -$76.77M 10-K · filed 2017-02-28 | |||||||
| 2015-12-31 | $5.89M 10-K · filed 2017-02-28 | |||||||
| 2015-06-30 | $10.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $351.00K 10-Q · filed 2015-08-10 | $13.83M derived: sum of 3 quarters · filed 2017-02-28 | $16.46M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$10.42M 10-Q · filed 2015-05-11 | $3.06M derived: sum of 2 quarters · filed 2017-02-28 | $5.69M derived: sum of 3 quarters · filed 2017-02-28 | -$180.00K derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $13.48M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $16.11M derived: sum of 2 quarters · filed 2017-02-28 | $10.24M derived: sum of 3 quarters · filed 2017-02-28 | -$32.95M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$3.24M derived: sum of 2 quarters · filed 2015-08-10 | -$46.43M 10-Q · filed 2014-11-10 | -$44.42M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$5.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$49.06M 10-Q · filed 2015-08-10 | -$47.04M derived: sum of 3 quarters · filed 2016-02-29 | -$47.37M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$43.19M 10-Q · filed 2015-05-11 | -$41.17M derived: sum of 2 quarters · filed 2016-02-29 | -$41.50M derived: sum of 3 quarters · filed 2016-02-29 | -$41.58M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.69M derived: sum of 2 quarters · filed 2016-02-29 | $1.61M derived: sum of 3 quarters · filed 2016-02-29 | -$47.87M 10-K · filed 2016-02-29 | -$47.87M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | -$325.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$405.00K derived: sum of 2 quarters · filed 2014-11-10 | -$49.89M 10-Q · filed 2014-11-10 | -$49.89M 10-Q · filed 2013-11-08 | -$50.43M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-06-30 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$49.56M 10-Q · filed 2014-08-11 | -$49.56M 10-Q · filed 2013-08-07 | -$50.10M derived: sum of 3 quarters · filed 2015-03-02 | -$50.27M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-03-31 | -$49.48M 10-Q · filed 2014-05-12 | -$49.48M 10-Q · filed 2013-05-08 | -$50.02M derived: sum of 2 quarters · filed 2015-03-02 | -$50.19M derived: sum of 3 quarters · filed 2015-03-02 | -$50.91M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | -$539.84K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$707.35K derived: sum of 2 quarters · filed 2015-03-02 | -$1.43M derived: sum of 3 quarters · filed 2015-03-02 | -$1.41M 10-K · filed 2015-03-02 | -$1.41M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | -$167.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$889.01K derived: sum of 2 quarters · filed 2013-11-08 | -$873.16K 10-Q · filed 2013-11-08 | -$1.43M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$721.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$705.65K 10-Q · filed 2013-08-07 | -$1.26M derived: sum of 3 quarters · filed 2014-02-28 | -$1.30M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $15.84K 10-Q · filed 2013-05-08 | -$541.14K derived: sum of 2 quarters · filed 2014-02-28 | -$580.10K derived: sum of 3 quarters · filed 2014-02-28 | -$609.64K derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | -$556.99K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$595.95K derived: sum of 2 quarters · filed 2014-02-28 | -$625.49K derived: sum of 3 quarters · filed 2014-02-28 | -$828.51K 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | -$38.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$68.50K derived: sum of 2 quarters · filed 2012-11-08 | -$271.52K 10-Q · filed 2012-11-08 | -$602.26K derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | -$29.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$232.56K 10-Q · filed 2012-08-09 | -$563.30K derived: sum of 3 quarters · filed 2013-03-01 | -$623.94K derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | -$203.02K 10-Q · filed 2012-05-07 | -$533.76K derived: sum of 2 quarters · filed 2013-03-01 | -$594.40K derived: sum of 3 quarters · filed 2013-03-01 | |||||
| 2010-12-31 | -$330.74K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$391.38K derived: sum of 2 quarters · filed 2013-03-01 | -$646.54K 10-K · filed 2013-03-01 | |||||
| 2010-09-30 | -$60.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$315.81K 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | -$255.17K 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | -$1.46M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |